Followers | 42 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Monday, October 31, 2022 8:12:48 AM
The April 19 Prospectus and this prospectus supplement relate to the issuance by us of up to an aggregate of (i) 22,029,279 shares of our common stock that may be issued upon exercise of warrants to purchase common stock at an exercise price of $11.50 per share (the “public warrants”) issued by AMCI Acquisition Corp. (“AMCI”) in its initial public offering; (ii) 3,940,278 shares of our common stock that may be issued upon exercise of placement warrants at an exercise price of $11.50 per share that were originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated simultaneously with AMCI’s IPO (the “placement warrants”); and (iii) up to an aggregate of 400,000 shares of our common stock that may be issued upon the exercise of the working capital warrants at an exercise price of $11.50 per share that were issued to the Sponsor in connection with loans made by it to AMCI prior to the closing of the Business Combination, (the “working capital warrants” and, together with the placement warrants and the public warrants, the “warrants”).
The April 19 Prospectus and this prospectus supplement also relate to the offer and sale, from time to time, by the selling securityholders named in the April 19 Prospectus or any of their permitted transferees, of (i) up to an aggregate of 6,500,000 shares of our common stock that were issued to certain investors in a private placement in connection with the closing of the Business Combination; (ii) up to an aggregate of 12,370,323 shares of our common stock otherwise held by the selling securityholders; (iii) up to an aggregate of 3,940,278 shares of our common stock that may be issued upon exercise of the placement warrants held by the selling securityholders; (iv) up to an aggregate of 400,000 shares of our common stock that may be issued upon the exercise of the working capital warrants held by the selling securityholders and (v) up to an aggregate of 3,940,278 placement warrants and 400,000 working capital warrants held by the selling securityholders, as further described in the April 19 Prospectus. The April 19 Prospectus and this prospectus supplement also cover any additional securities that may become issuable by reason of share splits, share dividends or other similar transactions.
The April 28 Prospectus relates to the offer and sale, from time to time, by the selling securityholders named in the April 28 Prospectus or any of their permitted transferees of up to an aggregate of 10,152,865 shares of our common stock, consisting of (i) 5,124,846 shares issued to F.E.R. fischer Edelstahlrohre GmbH on August 31, 2021 pursuant to the Share Purchase Agreement, dated as of June 25, 2021, and (ii) 5,028,019 shares held by other selling securityholders. The April 28 Prospectus and this prospectus supplement also covers any additional securities that may become issuable by reason of share splits, share dividends or other similar transactions.
Our common stock and warrants are listed on Nasdaq under the symbols “ADN” and “ADNWW”, respectively. On October 13, 2022, the closing price of our common stock was $2.13 per share and the closing price of our warrants was $0.329 per share.
This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
Investing in our securities involves risks that are described in the “Risk Factors” section beginning on page 13 of the Prospectus.
Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is October 13, 2022.
”
my posts are always theory and not financial advice
Recent ADN News
- Advent Technologies Receives Nasdaq Notification Regarding Compliance with Listing Requirements and Appoints Three New Directors • Business Wire • 09/04/2024 10:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 09:03:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 11:16:50 AM
- Advent Technologies Reports Q4 2023 Results • Business Wire • 08/20/2024 11:00:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:08:28 PM
- Advent Technologies Announces Date for Fourth Quarter and Fiscal 2023 Earnings Call • Business Wire • 08/14/2024 01:28:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 09:22:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:26:42 PM
- Advent Technologies Reaches Agreement for up to $3 Million in Debt from Institutional Investor • Business Wire • 08/05/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 09:30:56 PM
- Advent Technologies Update on Streamlining Operations • Business Wire • 07/11/2024 06:22:00 PM
- Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-Q • Business Wire • 05/29/2024 06:50:00 PM
- Advent Technologies Holdings Announces Effective Date of Reverse Stock Split • Business Wire • 05/09/2024 05:30:00 PM
- Advent Technologies Holdings Approves Reverse Stock Split • Business Wire • 05/01/2024 01:10:00 PM
- Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K • Business Wire • 04/23/2024 08:58:00 PM
- Advent Technologies Signs Strategic Joint Development Agreement with Siemens Energy to Expedite the Decarbonization of the Maritime Sector • Business Wire • 04/04/2024 12:00:00 PM
- Advent Technologies Participates in $12.4 Million Project to Reduce GHG Emissions in the Maritime Sector • Business Wire • 03/05/2024 01:15:00 PM
- Advent Technologies Receives Formal Invitation from Greek State for €24 Million Grant for the Green HiPo IPCEI Project • Business Wire • 02/26/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 12:30:48 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 08:52:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:00:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/17/2024 10:30:11 PM
- Advent Technologies Announces Appointment of Naiem Hussain as Chief Financial Officer • Business Wire • 01/11/2024 11:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:17:12 PM
- Advent Technologies Secures Funding from Danish Energy Technology Development and Demonstration Program for Innovative R&D Project • Business Wire • 01/08/2024 01:35:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM